Speciation analysis of Sb(III) and Sb(V) in antileishmaniotic drug using Dowex 1×4 resin from hydrochloric acid solution

Journal of Pharmaceutical and Biomedical Analysis

Volumn 52, Issue 5, 2010, Pages 747-751

  Lukaszczyk L ^a   Zyrnicki, W ^a  

^a WROCLAW UNIVERSITY OF TECHNOLOGY   (Poland)

Author keywords

Dowex 1 4; Inductively coupled plasma optical emission spectrometry; Meglumine antimoniate; Solid phase extraction; Speciation analysis of antimony

Indexed keywords

ANTIMONY; ARSENIC; BISMUTH; CADMIUM; COPPER; HYDROCHLORIC ACID; LEAD; MANGANESE; MEGLUMINE ANTIMONATE; RESIN; ZINC;

ANALYTICAL PARAMETERS; ARTICLE; DRUG DETERMINATION; DRUG MIXTURE; MASS SPECTROMETRY; OXIDATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SEPARATION TECHNIQUE; SPECIATION ANALYSIS;

ANION EXCHANGE RESINS; ANTIMONY; ANTIPROTOZOAL AGENTS; HYDROCHLORIC ACID; LEISHMANIA; RESINS, SYNTHETIC; SOLUTIONS; SPECTROPHOTOMETRY, ATOMIC;

EID: 77950861425     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2010.02.009     Document Type: Article

References (22)

1. Demicheli C., de Figueiredo T.L., Calvalho S., Sinesterra R.D., Lopes J.C.D., Frézard F. Physico-chemical characterization of meglumine antimoniate. BioMetals 1999, 12:63-66.
2. Smichowski P. Antimony in the environment as a global pollutant: a review on analytical methodologies for its determination in atmospheric aerosol. Talanta 2008, 75:2-14.
3. Roberts W.L., McMurray W.J., Rainey P.M. Characterization of the antimonial antileishmanial agent meglumine antimonate (glucantime). Antimicrob. Agents Chemother. 1998, 42:1076-1082.
4. Mikeley N., Mortari S.R., Schubach A.O. Monitoring of total antimony and its species by ICP-MS and on-line ion chromatography in biological samples from patients treated for leishmaniasis. Anal. Bioanal. Chem. 2002, 372:495-502.
5. Flores E.M.M., Santos E.P., Barin J.S., Zanella R., Dressler V.L., Bittencourt C.F. Determination of antimony(III) and total antimony by hydride generation atomic absorption spectrometry in samples of injectable drugs used for leishmaniasis treatment. J. Anal. At. Spectrom. 2002, 17:819-823.
6. Flores E.M.M., Paula F.R., Silva E.F.B., Moraes D.P., Paniz J.N.G., Santos E.P., Dressler V.L., Bittencourt C.F. Selective determination of Sb(III) in drugs by flow injection hydride generation AAS. At. Spectrosc. 2003, 24:15-21.
7. Cabral L.M., Juliano V.N.M., Dias L.R.S., Dornelas C.B., Rodigues C.R., Villardi M., Castro H.C., Santos T.C. Speciation of antimony(III) and antimony(V) using hydride generation for meglumine antimoniate pharmaceutical formulations quality control. Mem. Inst. Oswaldo Cruz 2008, 103:130-137.
8. Santos V.S., Santos W.J.R., Kubota L.T., Tarley C.R.T. Speciation of Sb(III) and Sb(V) in meglumine antimoniate pharmaceutical formulations by PSA using carbon nanotube electrode. J. Pharmaceut. Biomed. Anal. 2009, 50:151-157.
9. Rath S., Jardim W.F., Dórea J.G. A simple spectrophotometric procedure for the determination of antimony(III) and (V) in antileishmanial drugs. Fresenius J. Anal. Chem. 1997, 358:548-550.
10. Gonzáles M.J.G., Renedo O.D., Martinez M.J.A. Simultaneous determination of antimony(III) and antimony(V) by UV-Vis spectroscopy and partial least squares method (PLS). Talanta 2005, 68:67-71.
11. Gonzáles M.J.G., Renedo O.D., Martinez M.J.A. Speciation of antimony by adsorptive stripping voltammetry using pyrogallol. Talanta 2007, 71:691-698.
12. Trivelin L.A., Rohwedder J.J.R., Rath S. Determination of pentavalent antimony in antileishmaniotic drugs using an automated system for liquid-liquid extraction with on-line detection. Talanta 2006, 68:1536-1543.
13. Mondal B.C., Das D., Das A.K. Synthesis and characterization of a new resin functionalized with 2-napthol-3,6-disulfonic acid and its application for the speciation of chromium in natural water. Talanta 2002, 56:145-152.
14. Gómez-Ariza J.L., Pozas J.A., Giraldez I., Morales E. Use of solid phase extraction for speciation of selenium compounds in aqueous environmental samples. Analyst 1999, 124:75-78.
15. Zih-Perényi K., Jankovics P., Sugár É., Lásztity A. Solid phase chelating extraction and separation of inorganic antimony species in pharmaceutical and water samples for graphite furnace atomic absorption spectrometry. Spectrochim. Acta B 2008, 63:445-449.
16. Camel V. Solid phase extraction of trace elements. Spectrochim. Acta B 2003, 58:1177-1233.
17. Filella M., May P.M. Computer simulation of the low-molecular-weight inorganic species distribution of antimony(III) and antimony(V) in natural waters. Geochim. Cosmochim. Acta 2003, 67:4013-4031.
18. Oelkers E.H., Sherman D.M., Ragnarsdottir K.V., Collins C. An EXAFS spectroscopic study of aqueous antimony(III)-chloride complexation at temperatures from 25 to 250°C. Chem. Geol. 1998, 151:21-27.
19. Kraus K.A., Nelson F. Proceedings of the First United Conference on the Peaceful Uses of Atomic Energy, vol. 7 1956, 113-131.
20. Frézard F., Martins P.S., Barbosa M.C.M., Pimenta A.M.C., Ferreira W.A., de Melo J.E., Mangrum J.B., Demicheli C. New insights into the chemical structure and composition of the pentavalent antimonial drugs, meglumine antimonate and sodium stibogluconate. J. Inorg. Biochem. 2008, 102:656-665.
21. Thompson M., Ellison S.L.R., Wood R. Harmonized guidelines for single laboratory validation of methods of analysis. Pure Appl. Chem. 2002, 74:835-855.
22. Filella M., Belzile N., Chen Y.-W. Antimony in the environment: a review focused on natural waters. I. Occurrence. Earth-Sci. Rev. 2002, 57:125-176.